| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2008 | EP1944303A1 Pyridine derivative substituted by heterocycle and fungicide containing the same |
| 07/16/2008 | EP1944302A1 Alpha crystalline formation of strontium ranelate, method of preparing same and pharmaceutical compositions containing same |
| 07/16/2008 | EP1944301A1 Novel benzoxathiin derivative |
| 07/16/2008 | EP1944300A2 Prodrugs of aspartyl protease inhibitors |
| 07/16/2008 | EP1944298A1 Quinazoline derivative and pharmaceutical |
| 07/16/2008 | EP1944297A1 Solid and crystalline rimonabant and processes for preparation, and pharmaceutical composition thereof |
| 07/16/2008 | EP1944296A1 Amorphous phase of a substituted pyrazoline, its preparation and use as medicaments |
| 07/16/2008 | EP1944295A1 Non-racemic mixtures of (R)-N-piperidinyl-5-(4-chlorophenyl)1-(2,4-dichlorophenyl)-4,5-dihydro-1H-pyrazole-3-carboxamide and (S)-N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H-pyrazole-3-carboxamide |
| 07/16/2008 | EP1944294A1 Gamma-polymorph of a substituted pyrazoline, its preparation and use as medicaments |
| 07/16/2008 | EP1944293A1 Alpha-Polymorph of a substituted pyrazoline, its preparation and use as medicaments |
| 07/16/2008 | EP1944292A1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 07/16/2008 | EP1944291A1 Optically active cyclic alcohol compound and method for producing same |
| 07/16/2008 | EP1944290A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 07/16/2008 | EP1944289A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 07/16/2008 | EP1944042A1 Combinations for HCV treatment |
| 07/16/2008 | EP1944041A1 Therapeutic agent for neurogenic pain |
| 07/16/2008 | EP1944036A2 Improvements in and relating to drug delivery |
| 07/16/2008 | EP1944034A1 Adsorbent for advanced glycation endproducts |
| 07/16/2008 | EP1944033A2 Use of pectin hydrolysis products |
| 07/16/2008 | EP1944032A2 Biodegradable intraocular implants containing prostamides |
| 07/16/2008 | EP1944031A1 use of ivabradine for the treatment of endothelial dysfunction |
| 07/16/2008 | EP1944030A1 Agent for treatment of schizophrenia |
| 07/16/2008 | EP1944029A1 Pharmaceutical preparation having excellent photostability |
| 07/16/2008 | EP1944028A1 Solid oral forms of ebastine |
| 07/16/2008 | EP1944027A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 07/16/2008 | EP1944026A2 Use of EDG receptor binding agents in cancer |
| 07/16/2008 | EP1944025A1 Stable pharmaceutical compositions of orlistat |
| 07/16/2008 | EP1944024A1 O-substituted aniline derivative and antioxidant drug |
| 07/16/2008 | EP1944023A1 Product of liquorice root and oak rinds combined with dexpanthenol |
| 07/16/2008 | EP1944022A1 Pharmaceutical compositions combining analgesics and anticonvulsant agents for the treatment of chronic and acute pain |
| 07/16/2008 | EP1944021A1 Equol level regulator |
| 07/16/2008 | EP1944019A2 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 07/16/2008 | EP1944018A1 Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
| 07/16/2008 | EP1944017A2 Rapidly disintegrating tablet in the oral cavity |
| 07/16/2008 | EP1943340A2 Human microrna targets in hiv genome and a method of identification thereof |
| 07/16/2008 | EP1943266A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 07/16/2008 | EP1943257A2 Fibroblast activation protein inhibitor compounds and methods |
| 07/16/2008 | EP1943256A2 Crystalline forms of cefdinir potassium salt |
| 07/16/2008 | EP1943253A1 Novel crystalline forms |
| 07/16/2008 | EP1943251A2 A1 adenosine receptor agonists |
| 07/16/2008 | EP1943250A1 Fused and spirocycle compounds and the use thereof |
| 07/16/2008 | EP1943249A1 Inhibitors of the hiv integrase enzyme |
| 07/16/2008 | EP1943247A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors |
| 07/16/2008 | EP1943246A1 Aspartyl protease inhibitors |
| 07/16/2008 | EP1943245A2 1,3-disubstituted indole derivatives for use as ppar modulators |
| 07/16/2008 | EP1943244A1 Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors |
| 07/16/2008 | EP1943243A1 Kinase inhibitors |
| 07/16/2008 | EP1943242A1 Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists |
| 07/16/2008 | EP1943241A1 Pyrazoles useful in the treatment of inflammation |
| 07/16/2008 | EP1943235A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 07/16/2008 | EP1943234A1 Triazole compounds as lipoxygenase inhibitors |
| 07/16/2008 | EP1943233A2 Compounds and compositions for protein kinase inhbitors |
| 07/16/2008 | EP1943232A1 Squaric acid derivatives as inhibitors of histone deacetylase |
| 07/16/2008 | EP1943231A1 (hetero)aryl compounds with mch antagonistic activity and medicaments comprising these compounds |
| 07/16/2008 | EP1943230A2 Compounds which have activity at m1 receptor and their uses in medicine |
| 07/16/2008 | EP1943229A1 Benzimidazole derivatives for use as beta-3 receptor agonists |
| 07/16/2008 | EP1943227A1 Novel beta-agonists, process for their preparation and their use as medicaments |
| 07/16/2008 | EP1943226A2 Phenol ethers as modulators of the opioid receptors |
| 07/16/2008 | EP1943225A1 Pyrazoles useful in the treatment of inflammation |
| 07/16/2008 | EP1943224A2 Estrogen receptor modulators |
| 07/16/2008 | EP1943223A1 9-amino-acridine derivatives and their use for eliminating misfolded proteins |
| 07/16/2008 | EP1943222A1 Antibacterial active 5-chinolin derivative |
| 07/16/2008 | EP1943221A1 Piperazine amidines as antiviral agents |
| 07/16/2008 | EP1943219A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 07/16/2008 | EP1943217A1 Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses |
| 07/16/2008 | EP1943216A1 Prolinamide derivatives as sodium channel modulators |
| 07/16/2008 | EP1943215A2 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase iv and methods |
| 07/16/2008 | EP1943213A2 Ppar modulating biaromatic compounds |
| 07/16/2008 | EP1942985A1 Methods for reducing blood pressure |
| 07/16/2008 | EP1942938A1 Use of oligouronates for treating mucus hyperviscosity |
| 07/16/2008 | EP1942921A2 Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension |
| 07/16/2008 | EP1942920A1 Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same |
| 07/16/2008 | EP1942918A1 Black tea polyphenols and uses thereof |
| 07/16/2008 | EP1942916A1 Agent for protecting body cells |
| 07/16/2008 | EP1942912A1 Agent for applying to mucosa and method for production thereof |
| 07/16/2008 | EP1942911A1 Therapeutic molecules and their uses |
| 07/16/2008 | EP1942910A2 Drug-eluting stents coated with p2y12 receptor antagonist compound |
| 07/16/2008 | EP1942909A2 Methods for treating respiratory disorders |
| 07/16/2008 | EP1942908A2 Anti-viral topical gel formulations containing a diuretic such as furosemide and/or a cardiac glycoside such as digoxin |
| 07/16/2008 | EP1942907A2 Methods of using saha and erlotinib for treating cancer |
| 07/16/2008 | EP1942906A2 Methods for the preservation of platelet efficacy during storage |
| 07/16/2008 | EP1942905A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 07/16/2008 | EP1942904A2 Cholesteryl ester transfer protein inhibitors |
| 07/16/2008 | EP1942903A1 Potentiation of the therapeutic action of an opioid receptor agonist and/or inhibition or reversal of tolerance to opioid receptor agonists using an ultralow dose of an alpha-2 receptor antagonist |
| 07/16/2008 | EP1942902A1 Pharmaceutical preparation containing meloxicam |
| 07/16/2008 | EP1942901A2 Rifamycin analogs and uses thereof |
| 07/16/2008 | EP1942900A2 Use of pyrazolo [1,5-a] pyrimidine derivatives for inhibiting kinases methods for inhibiting protein kinases |
| 07/16/2008 | EP1942899A2 Mitotic kinesin inhibitors |
| 07/16/2008 | EP1942898A1 Dipeptidyl peptidase inhibitors for treating diabetes |
| 07/16/2008 | EP1942897A1 Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 07/16/2008 | EP1942896A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 07/16/2008 | EP1942895A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 07/16/2008 | EP1942894A1 Preparation for the treatment of diarrhoea |
| 07/16/2008 | EP1942893A2 Piperidine glycine transporter inhibitors |
| 07/16/2008 | EP1942892A1 Solid dispersions of opioid antagonists |
| 07/16/2008 | EP1942891A1 Novel combination of drugs as antidepressant |
| 07/16/2008 | EP1942890A2 Chemokine receptor binding compounds |
| 07/16/2008 | EP1942889A2 Use of bipyridine compound 'caerulomycin a' derivatives and analogs thereof as immunosuppressive agents |
| 07/16/2008 | EP1942888A2 Certain chemical entities, compositions, and methods |
| 07/16/2008 | EP1942887A1 Tacrolimus combination products |